Pharma & Healthcare
Global COX-2 Selective NSAIDs Market Research Report 2026
- Mar 14, 26
- ID: 731672
- Pages: 117
- Figures: 116
- Views: 5
This report delivers a comprehensive overview of the global COX-2 Selective NSAIDs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding COX-2 Selective NSAIDs. The COX-2 Selective NSAIDs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global COX-2 Selective NSAIDs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist COX-2 Selective NSAIDs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Teva
Mylan
Apotex
Lupin
Jiangsu Hengrui Medicine
Merck
Segment by Type
Celecoxib
Rofecoxib
Valdecoxib
Etoricoxib
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for COX-2 Selective NSAIDs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines COX-2 Selective NSAIDs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global COX-2 Selective NSAIDs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist COX-2 Selective NSAIDs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Teva
Mylan
Apotex
Lupin
Jiangsu Hengrui Medicine
Merck
Segment by Type
Celecoxib
Rofecoxib
Valdecoxib
Etoricoxib
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for COX-2 Selective NSAIDs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines COX-2 Selective NSAIDs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 COX-2 Selective NSAIDs Market Overview
1.1 Product Definition
1.2 COX-2 Selective NSAIDs by Type
1.2.1 Global COX-2 Selective NSAIDs Market Value by Type: 2025 vs 2032
1.2.2 Celecoxib
1.2.3 Rofecoxib
1.2.4 Valdecoxib
1.2.5 Etoricoxib
1.3 COX-2 Selective NSAIDs by Application
1.3.1 Global COX-2 Selective NSAIDs Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global COX-2 Selective NSAIDs Market Size Estimates and Forecasts
1.4.1 Global COX-2 Selective NSAIDs Revenue 2021–2032
1.4.2 Global COX-2 Selective NSAIDs Sales 2021–2032
1.4.3 Global COX-2 Selective NSAIDs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 COX-2 Selective NSAIDs Market Competition by Manufacturers
2.1 Global COX-2 Selective NSAIDs Sales Market Share by Manufacturers (2021–2026)
2.2 Global COX-2 Selective NSAIDs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global COX-2 Selective NSAIDs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of COX-2 Selective NSAIDs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of COX-2 Selective NSAIDs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of COX-2 Selective NSAIDs, Product Types and Applications
2.7 Global Key Manufacturers of COX-2 Selective NSAIDs, Date of Entry into the Industry
2.8 Global COX-2 Selective NSAIDs Market Competitive Situation and Trends
2.8.1 Global COX-2 Selective NSAIDs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global COX-2 Selective NSAIDs Players Market Share by Revenue
2.8.3 Global COX-2 Selective NSAIDs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global COX-2 Selective NSAIDs Market Scenario by Region
3.1 Global COX-2 Selective NSAIDs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global COX-2 Selective NSAIDs Sales by Region: 2021–2032
3.2.1 Global COX-2 Selective NSAIDs Sales by Region: 2021–2026
3.2.2 Global COX-2 Selective NSAIDs Sales by Region: 2027–2032
3.3 Global COX-2 Selective NSAIDs Revenue by Region: 2021–2032
3.3.1 Global COX-2 Selective NSAIDs Revenue by Region: 2021–2026
3.3.2 Global COX-2 Selective NSAIDs Revenue by Region: 2027–2032
3.4 North America COX-2 Selective NSAIDs Market Facts & Figures by Country
3.4.1 North America COX-2 Selective NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America COX-2 Selective NSAIDs Sales by Country (2021–2032)
3.4.3 North America COX-2 Selective NSAIDs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe COX-2 Selective NSAIDs Market Facts & Figures by Country
3.5.1 Europe COX-2 Selective NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe COX-2 Selective NSAIDs Sales by Country (2021–2032)
3.5.3 Europe COX-2 Selective NSAIDs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COX-2 Selective NSAIDs Market Facts & Figures by Region
3.6.1 Asia Pacific COX-2 Selective NSAIDs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific COX-2 Selective NSAIDs Sales by Region (2021–2032)
3.6.3 Asia Pacific COX-2 Selective NSAIDs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America COX-2 Selective NSAIDs Market Facts & Figures by Country
3.7.1 Latin America COX-2 Selective NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America COX-2 Selective NSAIDs Sales by Country (2021–2032)
3.7.3 Latin America COX-2 Selective NSAIDs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa COX-2 Selective NSAIDs Market Facts & Figures by Country
3.8.1 Middle East and Africa COX-2 Selective NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa COX-2 Selective NSAIDs Sales by Country (2021–2032)
3.8.3 Middle East and Africa COX-2 Selective NSAIDs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global COX-2 Selective NSAIDs Sales by Type (2021–2032)
4.1.1 Global COX-2 Selective NSAIDs Sales by Type (2021–2026)
4.1.2 Global COX-2 Selective NSAIDs Sales by Type (2027–2032)
4.1.3 Global COX-2 Selective NSAIDs Sales Market Share by Type (2021–2032)
4.2 Global COX-2 Selective NSAIDs Revenue by Type (2021–2032)
4.2.1 Global COX-2 Selective NSAIDs Revenue by Type (2021–2026)
4.2.2 Global COX-2 Selective NSAIDs Revenue by Type (2027–2032)
4.2.3 Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021–2032)
4.3 Global COX-2 Selective NSAIDs Price by Type (2021–2032)
5 Segment by Application
5.1 Global COX-2 Selective NSAIDs Sales by Application (2021–2032)
5.1.1 Global COX-2 Selective NSAIDs Sales by Application (2021–2026)
5.1.2 Global COX-2 Selective NSAIDs Sales by Application (2027–2032)
5.1.3 Global COX-2 Selective NSAIDs Sales Market Share by Application (2021–2032)
5.2 Global COX-2 Selective NSAIDs Revenue by Application (2021–2032)
5.2.1 Global COX-2 Selective NSAIDs Revenue by Application (2021–2026)
5.2.2 Global COX-2 Selective NSAIDs Revenue by Application (2027–2032)
5.2.3 Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021–2032)
5.3 Global COX-2 Selective NSAIDs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer COX-2 Selective NSAIDs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Teva COX-2 Selective NSAIDs Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mylan COX-2 Selective NSAIDs Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Apotex COX-2 Selective NSAIDs Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Lupin
6.5.1 Lupin Company Information
6.5.2 Lupin Description and Business Overview
6.5.3 Lupin COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Lupin COX-2 Selective NSAIDs Product Portfolio
6.5.5 Lupin Recent Developments/Updates
6.6 Jiangsu Hengrui Medicine
6.6.1 Jiangsu Hengrui Medicine Company Information
6.6.2 Jiangsu Hengrui Medicine Description and Business Overview
6.6.3 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolio
6.6.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Merck COX-2 Selective NSAIDs Product Portfolio
6.7.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COX-2 Selective NSAIDs Industry Chain Analysis
7.2 COX-2 Selective NSAIDs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COX-2 Selective NSAIDs Production Mode & Process Analysis
7.4 COX-2 Selective NSAIDs Sales and Marketing
7.4.1 COX-2 Selective NSAIDs Sales Channels
7.4.2 COX-2 Selective NSAIDs Distributors
7.5 COX-2 Selective NSAIDs Customer Analysis
8 COX-2 Selective NSAIDs Market Dynamics
8.1 COX-2 Selective NSAIDs Industry Trends
8.2 COX-2 Selective NSAIDs Market Drivers
8.3 COX-2 Selective NSAIDs Market Challenges
8.4 COX-2 Selective NSAIDs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 COX-2 Selective NSAIDs by Type
1.2.1 Global COX-2 Selective NSAIDs Market Value by Type: 2025 vs 2032
1.2.2 Celecoxib
1.2.3 Rofecoxib
1.2.4 Valdecoxib
1.2.5 Etoricoxib
1.3 COX-2 Selective NSAIDs by Application
1.3.1 Global COX-2 Selective NSAIDs Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global COX-2 Selective NSAIDs Market Size Estimates and Forecasts
1.4.1 Global COX-2 Selective NSAIDs Revenue 2021–2032
1.4.2 Global COX-2 Selective NSAIDs Sales 2021–2032
1.4.3 Global COX-2 Selective NSAIDs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 COX-2 Selective NSAIDs Market Competition by Manufacturers
2.1 Global COX-2 Selective NSAIDs Sales Market Share by Manufacturers (2021–2026)
2.2 Global COX-2 Selective NSAIDs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global COX-2 Selective NSAIDs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of COX-2 Selective NSAIDs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of COX-2 Selective NSAIDs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of COX-2 Selective NSAIDs, Product Types and Applications
2.7 Global Key Manufacturers of COX-2 Selective NSAIDs, Date of Entry into the Industry
2.8 Global COX-2 Selective NSAIDs Market Competitive Situation and Trends
2.8.1 Global COX-2 Selective NSAIDs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global COX-2 Selective NSAIDs Players Market Share by Revenue
2.8.3 Global COX-2 Selective NSAIDs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global COX-2 Selective NSAIDs Market Scenario by Region
3.1 Global COX-2 Selective NSAIDs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global COX-2 Selective NSAIDs Sales by Region: 2021–2032
3.2.1 Global COX-2 Selective NSAIDs Sales by Region: 2021–2026
3.2.2 Global COX-2 Selective NSAIDs Sales by Region: 2027–2032
3.3 Global COX-2 Selective NSAIDs Revenue by Region: 2021–2032
3.3.1 Global COX-2 Selective NSAIDs Revenue by Region: 2021–2026
3.3.2 Global COX-2 Selective NSAIDs Revenue by Region: 2027–2032
3.4 North America COX-2 Selective NSAIDs Market Facts & Figures by Country
3.4.1 North America COX-2 Selective NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America COX-2 Selective NSAIDs Sales by Country (2021–2032)
3.4.3 North America COX-2 Selective NSAIDs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe COX-2 Selective NSAIDs Market Facts & Figures by Country
3.5.1 Europe COX-2 Selective NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe COX-2 Selective NSAIDs Sales by Country (2021–2032)
3.5.3 Europe COX-2 Selective NSAIDs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COX-2 Selective NSAIDs Market Facts & Figures by Region
3.6.1 Asia Pacific COX-2 Selective NSAIDs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific COX-2 Selective NSAIDs Sales by Region (2021–2032)
3.6.3 Asia Pacific COX-2 Selective NSAIDs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America COX-2 Selective NSAIDs Market Facts & Figures by Country
3.7.1 Latin America COX-2 Selective NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America COX-2 Selective NSAIDs Sales by Country (2021–2032)
3.7.3 Latin America COX-2 Selective NSAIDs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa COX-2 Selective NSAIDs Market Facts & Figures by Country
3.8.1 Middle East and Africa COX-2 Selective NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa COX-2 Selective NSAIDs Sales by Country (2021–2032)
3.8.3 Middle East and Africa COX-2 Selective NSAIDs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global COX-2 Selective NSAIDs Sales by Type (2021–2032)
4.1.1 Global COX-2 Selective NSAIDs Sales by Type (2021–2026)
4.1.2 Global COX-2 Selective NSAIDs Sales by Type (2027–2032)
4.1.3 Global COX-2 Selective NSAIDs Sales Market Share by Type (2021–2032)
4.2 Global COX-2 Selective NSAIDs Revenue by Type (2021–2032)
4.2.1 Global COX-2 Selective NSAIDs Revenue by Type (2021–2026)
4.2.2 Global COX-2 Selective NSAIDs Revenue by Type (2027–2032)
4.2.3 Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021–2032)
4.3 Global COX-2 Selective NSAIDs Price by Type (2021–2032)
5 Segment by Application
5.1 Global COX-2 Selective NSAIDs Sales by Application (2021–2032)
5.1.1 Global COX-2 Selective NSAIDs Sales by Application (2021–2026)
5.1.2 Global COX-2 Selective NSAIDs Sales by Application (2027–2032)
5.1.3 Global COX-2 Selective NSAIDs Sales Market Share by Application (2021–2032)
5.2 Global COX-2 Selective NSAIDs Revenue by Application (2021–2032)
5.2.1 Global COX-2 Selective NSAIDs Revenue by Application (2021–2026)
5.2.2 Global COX-2 Selective NSAIDs Revenue by Application (2027–2032)
5.2.3 Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021–2032)
5.3 Global COX-2 Selective NSAIDs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer COX-2 Selective NSAIDs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Teva COX-2 Selective NSAIDs Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mylan COX-2 Selective NSAIDs Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Apotex COX-2 Selective NSAIDs Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Lupin
6.5.1 Lupin Company Information
6.5.2 Lupin Description and Business Overview
6.5.3 Lupin COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Lupin COX-2 Selective NSAIDs Product Portfolio
6.5.5 Lupin Recent Developments/Updates
6.6 Jiangsu Hengrui Medicine
6.6.1 Jiangsu Hengrui Medicine Company Information
6.6.2 Jiangsu Hengrui Medicine Description and Business Overview
6.6.3 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolio
6.6.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck COX-2 Selective NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Merck COX-2 Selective NSAIDs Product Portfolio
6.7.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COX-2 Selective NSAIDs Industry Chain Analysis
7.2 COX-2 Selective NSAIDs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COX-2 Selective NSAIDs Production Mode & Process Analysis
7.4 COX-2 Selective NSAIDs Sales and Marketing
7.4.1 COX-2 Selective NSAIDs Sales Channels
7.4.2 COX-2 Selective NSAIDs Distributors
7.5 COX-2 Selective NSAIDs Customer Analysis
8 COX-2 Selective NSAIDs Market Dynamics
8.1 COX-2 Selective NSAIDs Industry Trends
8.2 COX-2 Selective NSAIDs Market Drivers
8.3 COX-2 Selective NSAIDs Market Challenges
8.4 COX-2 Selective NSAIDs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global COX-2 Selective NSAIDs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global COX-2 Selective NSAIDs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global COX-2 Selective NSAIDs Market Competitive Situation by Manufacturers in 2025
Table 4. Global COX-2 Selective NSAIDs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global COX-2 Selective NSAIDs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global COX-2 Selective NSAIDs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market COX-2 Selective NSAIDs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of COX-2 Selective NSAIDs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of COX-2 Selective NSAIDs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of COX-2 Selective NSAIDs, Product Types and Applications
Table 12. Global Key Manufacturers of COX-2 Selective NSAIDs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global COX-2 Selective NSAIDs Companies by Tier (Tier 1, Tier 2, Tier 3), based on COX-2 Selective NSAIDs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global COX-2 Selective NSAIDs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global COX-2 Selective NSAIDs Sales by Region (K Units), 2021–2026
Table 18. Global COX-2 Selective NSAIDs Sales Market Share by Region (2021–2026)
Table 19. Global COX-2 Selective NSAIDs Sales by Region (K Units), 2027–2032
Table 20. Global COX-2 Selective NSAIDs Sales Market Share by Region (2027–2032)
Table 21. Global COX-2 Selective NSAIDs Revenue by Region (US$ Million), 2021–2026
Table 22. Global COX-2 Selective NSAIDs Revenue Market Share by Region (2021–2026)
Table 23. Global COX-2 Selective NSAIDs Revenue by Region (US$ Million), 2027–2032
Table 24. Global COX-2 Selective NSAIDs Revenue Market Share by Region (2027–2032)
Table 25. North America COX-2 Selective NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America COX-2 Selective NSAIDs Sales by Country (K Units), 2021–2026
Table 27. North America COX-2 Selective NSAIDs Sales by Country (K Units), 2027–2032
Table 28. North America COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2021–2026
Table 29. North America COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe COX-2 Selective NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe COX-2 Selective NSAIDs Sales by Country (K Units), 2021–2026
Table 32. Europe COX-2 Selective NSAIDs Sales by Country (K Units), 2027–2032
Table 33. Europe COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific COX-2 Selective NSAIDs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific COX-2 Selective NSAIDs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific COX-2 Selective NSAIDs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific COX-2 Selective NSAIDs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific COX-2 Selective NSAIDs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America COX-2 Selective NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America COX-2 Selective NSAIDs Sales by Country (K Units), 2021–2026
Table 42. Latin America COX-2 Selective NSAIDs Sales by Country (K Units), 2027–2032
Table 43. Latin America COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa COX-2 Selective NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa COX-2 Selective NSAIDs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa COX-2 Selective NSAIDs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2027–2032
Table 50. Global COX-2 Selective NSAIDs Sales (K Units) by Type (2021–2026)
Table 51. Global COX-2 Selective NSAIDs Sales (K Units) by Type (2027–2032)
Table 52. Global COX-2 Selective NSAIDs Sales Market Share by Type (2021–2026)
Table 53. Global COX-2 Selective NSAIDs Sales Market Share by Type (2027–2032)
Table 54. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021–2026)
Table 57. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2027–2032)
Table 58. Global COX-2 Selective NSAIDs Price (US$/Unit) by Type (2021–2026)
Table 59. Global COX-2 Selective NSAIDs Price (US$/Unit) by Type (2027–2032)
Table 60. Global COX-2 Selective NSAIDs Sales (K Units) by Application (2021–2026)
Table 61. Global COX-2 Selective NSAIDs Sales (K Units) by Application (2027–2032)
Table 62. Global COX-2 Selective NSAIDs Sales Market Share by Application (2021–2026)
Table 63. Global COX-2 Selective NSAIDs Sales Market Share by Application (2027–2032)
Table 64. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021–2026)
Table 67. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2027–2032)
Table 68. Global COX-2 Selective NSAIDs Price (US$/Unit) by Application (2021–2026)
Table 69. Global COX-2 Selective NSAIDs Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer COX-2 Selective NSAIDs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Teva COX-2 Selective NSAIDs Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Mylan COX-2 Selective NSAIDs Product
Table 84. Mylan Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Apotex COX-2 Selective NSAIDs Product
Table 89. Apotex Recent Developments/Updates
Table 90. Lupin Company Information
Table 91. Lupin Description and Business Overview
Table 92. Lupin COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Lupin COX-2 Selective NSAIDs Product
Table 94. Lupin Recent Developments/Updates
Table 95. Jiangsu Hengrui Medicine Company Information
Table 96. Jiangsu Hengrui Medicine Description and Business Overview
Table 97. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product
Table 99. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 100. Merck Company Information
Table 101. Merck Description and Business Overview
Table 102. Merck COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Merck COX-2 Selective NSAIDs Product
Table 104. Merck Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. COX-2 Selective NSAIDs Distributors List
Table 108. COX-2 Selective NSAIDs Customers List
Table 109. COX-2 Selective NSAIDs Market Trends
Table 110. COX-2 Selective NSAIDs Market Drivers
Table 111. COX-2 Selective NSAIDs Market Challenges
Table 112. COX-2 Selective NSAIDs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of COX-2 Selective NSAIDs
Figure 2. Global COX-2 Selective NSAIDs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global COX-2 Selective NSAIDs Market Share by Type: 2025 & 2032
Figure 4. Celecoxib Product Picture
Figure 5. Rofecoxib Product Picture
Figure 6. Valdecoxib Product Picture
Figure 7. Etoricoxib Product Picture
Figure 8. Global COX-2 Selective NSAIDs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global COX-2 Selective NSAIDs Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global COX-2 Selective NSAIDs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global COX-2 Selective NSAIDs Market Size (US$ Million), 2021–2032
Figure 15. Global COX-2 Selective NSAIDs Sales (K Units), 2021–2032
Figure 16. Global COX-2 Selective NSAIDs Average Price (US$/Unit), 2021–2032
Figure 17. COX-2 Selective NSAIDs Report Years Considered
Figure 18. COX-2 Selective NSAIDs Sales Share by Manufacturers in 2025
Figure 19. Global COX-2 Selective NSAIDs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global COX-2 Selective NSAIDs Players: Market Share by Revenue in COX-2 Selective NSAIDs in 2025
Figure 21. COX-2 Selective NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global COX-2 Selective NSAIDs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America COX-2 Selective NSAIDs Sales Market Share by Country (2021–2032)
Figure 24. North America COX-2 Selective NSAIDs Revenue Market Share by Country (2021–2032)
Figure 25. United States COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe COX-2 Selective NSAIDs Sales Market Share by Country (2021–2032)
Figure 28. Europe COX-2 Selective NSAIDs Revenue Market Share by Country (2021–2032)
Figure 29. Germany COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific COX-2 Selective NSAIDs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific COX-2 Selective NSAIDs Revenue Market Share by Region (2021–2032)
Figure 36. China COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America COX-2 Selective NSAIDs Sales Market Share by Country (2021–2032)
Figure 44. Latin America COX-2 Selective NSAIDs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa COX-2 Selective NSAIDs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa COX-2 Selective NSAIDs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of COX-2 Selective NSAIDs by Type (2021–2032)
Figure 55. Global Revenue Market Share of COX-2 Selective NSAIDs by Type (2021–2032)
Figure 56. Global COX-2 Selective NSAIDs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of COX-2 Selective NSAIDs by Application (2021–2032)
Figure 58. Global Revenue Market Share of COX-2 Selective NSAIDs by Application (2021–2032)
Figure 59. Global COX-2 Selective NSAIDs Price (US$/Unit) by Application (2021–2032)
Figure 60. COX-2 Selective NSAIDs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global COX-2 Selective NSAIDs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global COX-2 Selective NSAIDs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global COX-2 Selective NSAIDs Market Competitive Situation by Manufacturers in 2025
Table 4. Global COX-2 Selective NSAIDs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global COX-2 Selective NSAIDs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global COX-2 Selective NSAIDs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market COX-2 Selective NSAIDs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of COX-2 Selective NSAIDs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of COX-2 Selective NSAIDs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of COX-2 Selective NSAIDs, Product Types and Applications
Table 12. Global Key Manufacturers of COX-2 Selective NSAIDs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global COX-2 Selective NSAIDs Companies by Tier (Tier 1, Tier 2, Tier 3), based on COX-2 Selective NSAIDs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global COX-2 Selective NSAIDs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global COX-2 Selective NSAIDs Sales by Region (K Units), 2021–2026
Table 18. Global COX-2 Selective NSAIDs Sales Market Share by Region (2021–2026)
Table 19. Global COX-2 Selective NSAIDs Sales by Region (K Units), 2027–2032
Table 20. Global COX-2 Selective NSAIDs Sales Market Share by Region (2027–2032)
Table 21. Global COX-2 Selective NSAIDs Revenue by Region (US$ Million), 2021–2026
Table 22. Global COX-2 Selective NSAIDs Revenue Market Share by Region (2021–2026)
Table 23. Global COX-2 Selective NSAIDs Revenue by Region (US$ Million), 2027–2032
Table 24. Global COX-2 Selective NSAIDs Revenue Market Share by Region (2027–2032)
Table 25. North America COX-2 Selective NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America COX-2 Selective NSAIDs Sales by Country (K Units), 2021–2026
Table 27. North America COX-2 Selective NSAIDs Sales by Country (K Units), 2027–2032
Table 28. North America COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2021–2026
Table 29. North America COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe COX-2 Selective NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe COX-2 Selective NSAIDs Sales by Country (K Units), 2021–2026
Table 32. Europe COX-2 Selective NSAIDs Sales by Country (K Units), 2027–2032
Table 33. Europe COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific COX-2 Selective NSAIDs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific COX-2 Selective NSAIDs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific COX-2 Selective NSAIDs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific COX-2 Selective NSAIDs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific COX-2 Selective NSAIDs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America COX-2 Selective NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America COX-2 Selective NSAIDs Sales by Country (K Units), 2021–2026
Table 42. Latin America COX-2 Selective NSAIDs Sales by Country (K Units), 2027–2032
Table 43. Latin America COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa COX-2 Selective NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa COX-2 Selective NSAIDs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa COX-2 Selective NSAIDs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa COX-2 Selective NSAIDs Revenue by Country (US$ Million), 2027–2032
Table 50. Global COX-2 Selective NSAIDs Sales (K Units) by Type (2021–2026)
Table 51. Global COX-2 Selective NSAIDs Sales (K Units) by Type (2027–2032)
Table 52. Global COX-2 Selective NSAIDs Sales Market Share by Type (2021–2026)
Table 53. Global COX-2 Selective NSAIDs Sales Market Share by Type (2027–2032)
Table 54. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021–2026)
Table 57. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2027–2032)
Table 58. Global COX-2 Selective NSAIDs Price (US$/Unit) by Type (2021–2026)
Table 59. Global COX-2 Selective NSAIDs Price (US$/Unit) by Type (2027–2032)
Table 60. Global COX-2 Selective NSAIDs Sales (K Units) by Application (2021–2026)
Table 61. Global COX-2 Selective NSAIDs Sales (K Units) by Application (2027–2032)
Table 62. Global COX-2 Selective NSAIDs Sales Market Share by Application (2021–2026)
Table 63. Global COX-2 Selective NSAIDs Sales Market Share by Application (2027–2032)
Table 64. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global COX-2 Selective NSAIDs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021–2026)
Table 67. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2027–2032)
Table 68. Global COX-2 Selective NSAIDs Price (US$/Unit) by Application (2021–2026)
Table 69. Global COX-2 Selective NSAIDs Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer COX-2 Selective NSAIDs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Teva COX-2 Selective NSAIDs Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Mylan COX-2 Selective NSAIDs Product
Table 84. Mylan Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Apotex COX-2 Selective NSAIDs Product
Table 89. Apotex Recent Developments/Updates
Table 90. Lupin Company Information
Table 91. Lupin Description and Business Overview
Table 92. Lupin COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Lupin COX-2 Selective NSAIDs Product
Table 94. Lupin Recent Developments/Updates
Table 95. Jiangsu Hengrui Medicine Company Information
Table 96. Jiangsu Hengrui Medicine Description and Business Overview
Table 97. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product
Table 99. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 100. Merck Company Information
Table 101. Merck Description and Business Overview
Table 102. Merck COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Merck COX-2 Selective NSAIDs Product
Table 104. Merck Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. COX-2 Selective NSAIDs Distributors List
Table 108. COX-2 Selective NSAIDs Customers List
Table 109. COX-2 Selective NSAIDs Market Trends
Table 110. COX-2 Selective NSAIDs Market Drivers
Table 111. COX-2 Selective NSAIDs Market Challenges
Table 112. COX-2 Selective NSAIDs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of COX-2 Selective NSAIDs
Figure 2. Global COX-2 Selective NSAIDs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global COX-2 Selective NSAIDs Market Share by Type: 2025 & 2032
Figure 4. Celecoxib Product Picture
Figure 5. Rofecoxib Product Picture
Figure 6. Valdecoxib Product Picture
Figure 7. Etoricoxib Product Picture
Figure 8. Global COX-2 Selective NSAIDs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global COX-2 Selective NSAIDs Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global COX-2 Selective NSAIDs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global COX-2 Selective NSAIDs Market Size (US$ Million), 2021–2032
Figure 15. Global COX-2 Selective NSAIDs Sales (K Units), 2021–2032
Figure 16. Global COX-2 Selective NSAIDs Average Price (US$/Unit), 2021–2032
Figure 17. COX-2 Selective NSAIDs Report Years Considered
Figure 18. COX-2 Selective NSAIDs Sales Share by Manufacturers in 2025
Figure 19. Global COX-2 Selective NSAIDs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global COX-2 Selective NSAIDs Players: Market Share by Revenue in COX-2 Selective NSAIDs in 2025
Figure 21. COX-2 Selective NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global COX-2 Selective NSAIDs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America COX-2 Selective NSAIDs Sales Market Share by Country (2021–2032)
Figure 24. North America COX-2 Selective NSAIDs Revenue Market Share by Country (2021–2032)
Figure 25. United States COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe COX-2 Selective NSAIDs Sales Market Share by Country (2021–2032)
Figure 28. Europe COX-2 Selective NSAIDs Revenue Market Share by Country (2021–2032)
Figure 29. Germany COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific COX-2 Selective NSAIDs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific COX-2 Selective NSAIDs Revenue Market Share by Region (2021–2032)
Figure 36. China COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America COX-2 Selective NSAIDs Sales Market Share by Country (2021–2032)
Figure 44. Latin America COX-2 Selective NSAIDs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa COX-2 Selective NSAIDs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa COX-2 Selective NSAIDs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE COX-2 Selective NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of COX-2 Selective NSAIDs by Type (2021–2032)
Figure 55. Global Revenue Market Share of COX-2 Selective NSAIDs by Type (2021–2032)
Figure 56. Global COX-2 Selective NSAIDs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of COX-2 Selective NSAIDs by Application (2021–2032)
Figure 58. Global Revenue Market Share of COX-2 Selective NSAIDs by Application (2021–2032)
Figure 59. Global COX-2 Selective NSAIDs Price (US$/Unit) by Application (2021–2032)
Figure 60. COX-2 Selective NSAIDs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232